A comprehensive view of European Medicines Agency. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AptarGroup Inc. focuses on compliance and contamination control in pharma packaging; supports EMA GMP Annex 1 revisions to ensure standards with isolators, RABS, and PremiumFill components
Published: July 06, 2024 by Industry Intelligence Inc.
Dupixent approved in EU as first targeted therapy for COPD; approval based on phase 3 studies showing reduced exacerbations, lung function improvement in 220,000 patients
Published: July 03, 2024 by Sanofi SA
AstraZeneca's sipavibart submission accepted by EMA for accelerated COVID-19 prevention assessment; SUPERNOVA Phase III trial showed significant reduction in COVID-19 incidence among immunocompromised patients
Published: July 01, 2024 by AstraZeneca AB
Roche's Vabysmo receives positive opinion from EMA's CHMP for treating macular edema secondary to RVO; final decision expected soon, based on Phase 3 studies of over 1,200 participants
Published: June 28, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Roche's PiaSky poised to become first monthly subcutaneous treatment for PNH in the EU; CHMP positive opinion based on COMMODORE 2 study showing comparable safety to IV eculizumab
Published: June 28, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count